Danone, FR0000120644

Danone stock keeps 2026 outlook after 4% Q3 growth

Published on 11/07/2026 at 11:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Danone stock reported broad-based third-quarter growth and kept its full-year outlook. A Shanghai research center adds a nutrition innovation focus in China.

Danone combines growth with innovation

  • Third-quarter sales rose on a like-for-like basis across all major regions.
  • Management retained its full-year sales and recurring operating income outlook.
  • A new Shanghai research center broadens Danone's nutrition innovation focus in China.
Danone, FR0000120644, Illustration mit AI erstellt.

Danone reported broad-based third-quarter growth on October 28, with sales of 7,233 million euros up 4.0 percent on a like-for-like basis. The company kept its 2026 outlook, while price increases continued to contribute more than volume and mix.

Danone stock traded at 66.94 euros on Lang & Schwarz at 11:44 CET on Saturday, November 7, 0.33 percent below the Xetra close of Friday, November 6. The comparison uses the latest completed Xetra session and places the weekend quote slightly below that reference.

Growth remains broad but price-led

Danone's Q3 release said growth reached 3.9 percent in Europe, the Middle East and Africa, 4.4 percent in the Americas and 3.6 percent in Asia-Pacific. Volume and mix contributed 0.4 percentage points, while pricing added 3.6 percentage points.

The regional mix remains relevant for investors. Danone cited actions to restore momentum in North American Essential Dairy Products, while Specialized Nutrition continued to support growth. In Asia-Pacific, the company described a weaker season for Mizone water, keeping execution and product momentum in China in focus.

Outlook stays unchanged

Management continues to target like-for-like sales growth of 3 to 5 percent in 2026. Recurring operating income is expected to grow faster than sales, preserving the company's medium-term ambition despite the pressure from softer volume trends in selected businesses.

Danone also announced a Shanghai Research & Innovation Center intended to accelerate nutrition innovation. The move adds a strategic development angle to the week's operating update, particularly in a market where medical nutrition and healthy-aging products remain important growth areas.

For investors, the combination of confirmed guidance and positive regional growth supports a steady operating picture, while the pricing-heavy growth mix and Mizone weakness remain the main execution points to watch.

View the real-time quote of Danone stock for the latest trading indication.

The CAC 40 provides the relevant French large-cap market context; see the latest CAC 40 market coverage.

More news and analyses on Danone stock.

Danone stock at a glance

  • Company: Danone
  • ISIN: FR0000120644
  • Ticker: BN
  • Home exchange: Euronext Paris
  • Lang & Schwarz quote: 66.94 euros, November 7, 2026, 11:44 CET
  • Change versus Xetra close: -0.33 percent versus 67.16 euros on November 6, 2026
  • Sector: Consumer staples
Disclaimer...
en | FR0000120644 | DANONE | boerse | 70473998 |